Xuelin (Steve) Wang
Lawyers
Filters
Broncus Holding HK$1.55 billion IPO
We advised Broncus on its IPO and HKEX listing
Kindstar Globalgene Technology HK$2.21 billion IPO
We advised Kindstar Global on its IPO and HKEX listing
Zhenro Properties Group RMB1.3 billion green high-yield notes offering
We advised the initial purchasers on the Regulation S offering of senior notes, issued under Zhenro’s green bond framework
Zylox-Tonbridge Medical Technology HK$2.56 billion IPO
We advised Zylox-Tonbridge Medical Technology on its IPO and HKEX listing
HUTCHMED HK$4.17 billion IPO and primary listing
The shares are listed on the Hong Kong Stock Exchange
Shui On Development $400 million sustainability-linked bonds offering
We advised the joint lead managers on the Regulation S offering
CARsgen Therapeutics HK$3.1 billion IPO
We advised CARsgen Therapeutics on its IPO and HKEX listing
Zhenro Properties Group $340 million high-yield notes offering
We advised the initial purchasers on the Regulation S offering
Zai Lab $857.5 million offering of American depositary shares and ordinary shares
We advised Zai Lab on the concurrent offerings
I-Mab $177 million follow-on secondary offering of ADSs
We advised the underwriters on the equity offering